Cargando…

Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics

Since the first published genome sequence of Trypanosoma cruzi in 2005, there have been tremendous technological advances in genomics, reverse genetics, and assay development for this elusive pathogen. However, there is still an unmet need for new and better drugs to treat Chagas disease. Here, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fesser, Anna, Beilstein, Sabina, Kaiser, Marcel, Schmidt, Remo S., Mäser, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610277/
https://www.ncbi.nlm.nih.gov/pubmed/37887733
http://dx.doi.org/10.3390/pathogens12101217